» Articles » PMID: 11154417

Subclinical Reactivation of Herpes Simplex Virus Type 1 in the Oral Cavity

Overview
Date 2001 Jan 12
PMID 11154417
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Reactivation in the oral cavity either symptomatically (recrudescence) or without symptoms (recurrence) may contribute to the transmission of herpes simplex virus type 1 (HSV-1), especially in critical areas of exposure such as dentistry. In order to measure the frequency of HSV-1 reactivation, nested polymerase chain reaction (PCR) was performed on oral swabs collected from 30 healthy people over a period of 58-161 days. In total 19 of 25 (76%) seropositive people were PCR-positive at least once, 6 of these 19 (32%) had recrudescence and 13 (68%) had only asymptomatic reactivation. Frequencies of additional recurrences were higher in people showing symptomatic reactivation than in those who had only recurrences. Recrudescence is a risk factor for elevated levels of asymptomatic HSV-shedding. In most cases HSV-1 was detected only by nested PCR investigated by early onset of therapy or time span before sampling.

Citing Articles

Absence of influence of polymorphisms of the MBL2 gene in oral infections by HSV-1 in individuals with HIV.

Barros K, Ribeiro Paulino M, Batista M, Alcino Monteiro Gueiros L, Souza P, Leao J Braz J Microbiol. 2019; 50(3):663-668.

PMID: 31001794 PMC: 6863302. DOI: 10.1007/s42770-019-00074-6.


Burning mouth syndrome due to herpes simplex virus type 1.

Nagel M, Choe A, Traktinskiy I, Gilden D BMJ Case Rep. 2015; 2015.

PMID: 25833911 PMC: 4401976. DOI: 10.1136/bcr-2015-209488.


Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture.

Semenkow S, Johnson N, Maggs D, Margulies B Virol J. 2014; 11:34.

PMID: 24558980 PMC: 3939932. DOI: 10.1186/1743-422X-11-34.


Silicone-acyclovir controlled release devices suppress primary herpes simplex virus-2 and varicella zoster virus infections in vitro.

Berkower C, Johnson N, Longdo S, McGusty-Robinson S, Semenkow S, Margulies B Adv Pharmacol Sci. 2013; 2013:915159.

PMID: 23983683 PMC: 3747620. DOI: 10.1155/2013/915159.


Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

van Velzen M, Ouwendijk W, Selke S, Pas S, van Loenen F, Osterhaus A J Med Virol. 2013; 85(9):1669-77.

PMID: 23780621 PMC: 4020591. DOI: 10.1002/jmv.23634.